๐
Fasturtec
rasburicase
Hyperuricemia
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment and prophylaxis of acute hyperuricaemia, in order to prevent acute renal failure, in adults, children and adolescents (aged 0 to 17 years) with haematological malignancy with a high tumour burden and at risk of a rapid tumour lysis or shrinkage at initiation of chemotherapy.
โ ๏ธ Patient safety
No
๐ Past alerts (2)
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/fasturtec